New article: Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer in the US and China https://t.co/evYDLx1oAi #breastcancer #oncology https://t.co/vxpLuk34YW
906 followers
1,244 followers
RT @FrontPubHealth: New Research: Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer…
5,107 followers
New Research: Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer in the US and China: Objective To assess the economic evaluation of margetuximab plus chemotherapy over… https://t.co/ftp9b4kX8v #Public